Skip to content
Catalyst Biosciences
Primary Menu
About
Overview
Management Team
Board of Directors
Investors
Press Releases
Events and Presentations
Events
Presentations
Scientific Presentations and Publications
Financials & Filings
Stock Information
Stock Quote
Stock Chart
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
Investor FAQ
Contact
Pharmacokinetics of Subcutaneously Administered CB2679D/ISU304 in wild-type and Hemophilia B mice
Post navigation
Next:
Pharmacokinetics and Pharmacodynamics of daily Subcutaneously Administered Marzeptacog Alfa (Activated) in Hemophilia dogs
X
Previous
Next
